CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review
Developing CRISPR/CAS9 technologies for research and medicine - MedCrave online
First Trial of CRISPR-Edited T cells in Lung Cancer: Trends in Molecular Medicine
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy
:no_upscale()/cdn.vox-cdn.com/uploads/chorus_image/image/60457727/CRISPR_LEAD.0.jpg "CRISPR, one of the biggest science stories of the decade, explained - Vox")
CRISPR, one of the biggest science stories of the decade, explained - Vox
CRISPR, the disruptor : Nature News & Comment
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
CRISPR, the disruptor : Nature News & Comment
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
CRISPR-Cas 9 corrects genetic defects in mice
CRISPR gene editing - Wikipedia
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL
A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog
CRISPR algorithm predicts how well gene editing will work - Scope
PDF) The CRISPR tool kit for genome editing and beyond
Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine
New CRISPR genome-editing system can target disease-causing genetic variations – Harvard Gazette
CRISPR-Cas9 babies likely to die earlier, Berkeley study says | Science| In-depth reporting on science and technology | DW | 03.06.2019
CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American
Nature Medicine on Twitter: "Two studies find that #AAV-mediated #CRISPR/ Cas9 therapy extends life span and ameliorates disease-related phenotypes in a mouse model of #progeria. https://t.co/2LfOogSXLX and https://t.co/y5KjuD5Yjb… https://t.co/RMaa25wQoI"
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers
Kill Switch for CRISPR Could Make Gene Editing Safer - Scientific American
